ASHM, Sydney, 2020. 33p.
Examines the impact of COVID-19 on women’s health, with a focus on sexual and reproductive health, and blood borne viruses.
APSU & SHARC, Melbourne, 2020. 37p.
Report from consultation with 32 people accessing AOD treatment services between March and May 2020 when COVID-19 restrictions were put in place.
Infectious Disease Advisor, 2020.1p. article review.
Research found that no patients with both viruses progressed to a severe or critically ill status during hospitalization, but more than ¼ had abnormal liver function tests on admission.
Drug and Alcohol Research Centre, Sydney, 2020. 6p.
Identifies emerging trends of local and national concern in illicit drug markets: this 2020 survey is adapted to collect important data on people’s experiences during COVID-19.
NDARC, Sydney, 2020. 4p.
Changes in drug use, harm reduction behaviours, and drug/mental health treatment pre/post COVID-19 in a sample of Australians who use illicit drugs.
ASHM, Sydney, 2020. 16p.
Contains info and chart of elected COVID-19 treatment, prevention, observational and psychological studies and registries in Australasia at May 31st 2020
Australian Institute of Health and Welfare, Canberra, 2020. 104p.
Contents inc: illicit drug use, use by geographic areas, priority groups. Brief report also available.
ASHM, WHO Collaborating Centre for Viral Hepatitis, Peter Doherty Institute for Infection & Immunity, Sydney, 2020. 126p.
Contains updated estimates of chronic hep B & C prevalence, management & treatment at a state, territory, Primary Health Network, and Stat Area 3 level.
Bristol University PolicyBriefing, Bristol, 2020. 4p.
This study evaluates the clinical benefits and cost-effectiveness of needle and syringe programmes (NSP) and the use of low dead space syringes in reducing spread of HCV.
Hepatitis Queensland, Brisbane, 2020. 2p. infographic
How hep b and c are, and are not, transmitted, with info about prevention, testing and treatment measures.
Medically Supervised Injecting Room Review Panel, Melbourne, 2020. 139p.
Many MSIR service users have accessed other health and support services and the MSIR has provided screening, assessment and treatment initiation for blood-borne infections.
Family Planning Vic, Melbourne, 2020. 15:31 min podcast
The effect of undiagnosed STI's, availability of treatment, importance for young people to be able to ask for testing and discuss with sexual partners.
International Journal of Drug Policy (via Elsevier), New York, 2020. Detailed abstract.
Prison-based test-and-treat strategies could lead to the greatest declines in incidence over 2018–2030 and prevent the most new 1st chronic infections.
The Conversation, Melb/Sydney, 2020. 4p.
People who expose police or emergency workers to body fluids would be compelled to have blood tests for HIV, hep B and C under proposed NSW law but as a transmission risk this is not supported by evidence.
Hepatitis NSW, Sydney, 2020. Comic 29p.
HEP C! Are new hep C cures for real? Can you be retreated if needed? A ‘no fake news’ mythbuster edition.
Federal Practitioner (via US National Lib of Medicine), , Bethesda, 2018. 9p.
Depressive disorders found in many patients with liver disease: better screening and integrated/multidisciplinary care is needed.
The Conversation, Melbourne, Sydney. 4p.
This article outlines some of the health and mental health impacts of repeated stress, and what you can do to ameliorate the impacts.
Communicable Diseases Network Australia, Canberra, 2018. 50p.
Guidelines for health care workers and public health authorities when managing risk situations.
Hep Aust & Hep Vic, Canberra, 2020. Video 1:20 minutes
Animation: learn more about hepatitis C risk factors, symptoms, and a safe cure from Prem and Priya from the Indian community.
Int Jn for Equity in Health, London, 2020. 7p.
Developed with and including Aboriginal Health Practitioners this approach bridges gaps in the availability of services in a very remote community and improves the cascade of care.
Australian Indigenous HealthInfoNet, Perth, 2020. 111p.
Contains information about selected health conditions (including Hepatitis), risk and protective factors.
Kirby Institute, Sydney, 2020. 70p.
Account of progress towards hep C elimination in NSW, as framed by state, national, and global strategies.
For enquiries or feedback, please contact the librarian at Librarian@hepatitissa.asn.au.
| Address: | 3 Hackney Road Hackney SA 5069 |
| Phone: | (08) 8362 8443 |
| Fax: | (08) 8362 8559 |
| Email: | Librarian@hepatitissa.asn.au |
| Post: | PO Box 782 Kent Town SA 5071 |
Monday – Friday
9am to 5pm
Hepatitis SA is a non-profit, community-based organisation that provides information, education and support services to South Australians affected by hepatitis B and hepatitis C.